These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35720642)

  • 1. Low MARCO Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma Following Liver Transplantation.
    Zhang Q; Wei Y; Li Y; Jiao X
    Cancer Manag Res; 2022; 14():1935-1944. PubMed ID: 35720642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma.
    Sun H; Song J; Weng C; Xu J; Huang M; Huang Q; Sun R; Xiao W; Sun C
    J Gastroenterol Hepatol; 2017 May; 32(5):1107-1114. PubMed ID: 27806438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation.
    He JJ; Shang L; Yu QW; Jiao N; Qiu S; Zhu WX; Wu DF; Tian YE; Zhang Q
    World J Gastrointest Oncol; 2021 Jul; 13(7):716-731. PubMed ID: 34322200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy.
    Tsai MC; Lin CC; Chen DW; Liu YW; Wu YJ; Yen YH; Huang PY; Yao CC; Chuang CH; Hsiao CC
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34199695
    [No Abstract]   [Full Text] [Related]  

  • 8. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma.
    Xiao Y; Chen B; Yang K; Wang Q; Liu P; Gu Y; Zhong Q; Liu Z; He Y; Liu Q
    Exp Cell Res; 2019 Oct; 383(2):111542. PubMed ID: 31381879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.
    Yu JX; Chen Q; Yu YQ; Li SQ; Song JF
    Am J Cancer Res; 2016; 6(3):690-700. PubMed ID: 27152245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
    Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
    Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
    Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
    Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
    Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
    Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
    Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Huang X; Xiong Y; Yang J; Yang G; Li J
    Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China.
    Ke R; Lv L; Li J; Zhang X; Yang F; Zhang K; Jiang Y
    Oncol Lett; 2018 Sep; 16(3):3746-3756. PubMed ID: 30127985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma.
    Li J; Jin J; Liao M; Dang W; Chen X; Wu Y; Liao W
    Oncol Lett; 2018 Apr; 15(4):4248-4254. PubMed ID: 29541191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B; Mehta N; Sapisochin G; Roberts JP; Yao FY
    Liver Transpl; 2014 Aug; 20(8):945-51. PubMed ID: 24797281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
    Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
    Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.